Managing surgery in hemophilia with recombinant factor VIII Fc and factor IX Fc: Data on safety and effectiveness from phase 3 pivotal studies.
Pratima ChowdaryMargareta HolmströmJohnny N MahlanguMargaret C OzeloIngrid Pabinger-FaschingK John PasiMargaret V RagniAmy ShapiroChris BarnowskiStefan LethagenPublished in: Research and practice in thrombosis and haemostasis (2022)
rFVIIIFc and rFIXFc were efficacious and well tolerated for the management of perioperative hemostasis across a wide spectrum of major and minor surgeries in hemophilia.